Suppr超能文献

99mTc-甲氧基异丁基异腈和99mTc-替曲膦在恶性与非恶性乳腺细胞系中的摄取情况。

Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.

作者信息

Rodrigues M, Chehne F, Kalinowska W, Berghammer P, Zielinski C, Sinzinger H

机构信息

Department of Nuclear Medicine, University Hospital, Vienna, Austria.

出版信息

J Nucl Med. 2000 Sep;41(9):1495-9.

Abstract

UNLABELLED

The kinetics and cellular uptake of 99mTc-2-hexakis 2-methoxyiso-butyl-isonitrile (MIBI) and 99mTc-1 ,2-bis[bis(2-ethoxyethyl)phosphino]ethane (tetrofosmin) into malignant versus nonmalignant human breast cell lines were investigated and compared.

METHODS

At specific intervals after incubation at 37 degrees C and 22 degrees C with 99mTc-MIBI or 99mTc-tetrofosmin, the uptake characteristics of radiotracers into human adenocarcinoma breast cell lines MCF-7 and SK-BR-3 and human breast, nontumor cell line HBL-100 were assessed.

RESULTS

The uptake of 99mTc-MIBI and 99mTc-tetrofosmin was lower at an incubation temperature of 22 degrees C than that at 37 degrees C in the 3 cell lines. In MCF-7 and in SK-BR-3 cells the uptake of 99mTc-MIBI was significantly higher than the uptake of 99mTc-tetrofosmin. The uptake of 99mTc-MIBI was significantly higher into MCF-7 and SK-BR-3 cells than that into HBL-100 cells. In comparison with HBL-100 cells, uptake of 99mTc-tetrofosmin into SK-BR-3 cells was significantly higher, whereas uptake into MCF-7 cells was similar.

CONCLUSION

In vitro data suggest that 99mTc-MIBI may be a better tracer than 99mTc-tetrofosmin for discrimination between malignant and nonmalignant breast disease.

摘要

未标记

研究并比较了99mTc-2-六甲基-2-甲氧基异丁基异腈(MIBI)和99mTc-1,2-双[双(2-乙氧基乙基)膦基]乙烷(替曲膦)在恶性与非恶性人乳腺癌细胞系中的动力学及细胞摄取情况。

方法

在37℃和22℃下用99mTc-MIBI或99mTc-替曲膦孵育特定时间间隔后,评估放射性示踪剂在人腺癌乳腺癌细胞系MCF-7和SK-BR-3以及人乳腺非肿瘤细胞系HBL-100中的摄取特性。

结果

在这三种细胞系中,22℃孵育温度下99mTc-MIBI和99mTc-替曲膦的摄取量低于37℃时。在MCF-7和SK-BR-3细胞中,99mTc-MIBI的摄取量显著高于99mTc-替曲膦的摄取量。99mTc-MIBI在MCF-7和SK-BR-3细胞中的摄取量显著高于在HBL-100细胞中的摄取量。与HBL-100细胞相比,99mTc-替曲膦在SK-BR-3细胞中的摄取量显著更高,而在MCF-7细胞中的摄取量相似。

结论

体外数据表明,对于区分恶性和非恶性乳腺疾病,99mTc-MIBI可能是比99mTc-替曲膦更好的示踪剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验